Especially diseases of the cardiovascular system in patients with severe and medium-severe plaque psoriasis

Background. Psoriasis is a chronic inflammatory disease that associated with a decrease in life expectancy mostly due to cardiovascular disease. But prevalence of cardiovascular comorbidity in psoriasis patients has limited data. Objectives. To compare the prevalence of cardiovascular comorbidity in a hospital-treated cohort patients with severe psoriasis and psoriatic arthritis. Methods. 890 patients (M. - 516/F. - 347) with severe plaque psoriasis mean duration 25.7 ± 16.6 years, mean age of patients were 51.9 ± 11.6 years accordingly were included. Psoriasis patients with cardiovascular disease, including coronary heart disease, arterial hypertension, atherosclerosis and cerebrovascular accident were identify in the hospital Database reporting and coding by International Statistical Classification of Disease and Related Health Problems (ICD-10) between 2010-2015 years. M ± m, t-test, (%) were calculated. All p < 0.05 were considered to indicate statistical significance. Results. Male and Female patients were at the same age. 303 out of 890 patients (34.0%) had psoriatic arthritis, 587 out of 890 patients (66.0%) had severe plaque psoriasis with mean PASI 49.4 ± 0.5. 516 out of 890 patients (59.0%) had cardiovascular disease. Cardiovascular disease coding as I 00-I 99 were found significantly often in patients with psoriatic arthritis compare to patients with psoriasis - in 206 out of 303 patients (68.2%) and in 310 out of 587 patients (52.8%) accordingly (p < 0.05). Arterial hypertension coding as I 10-I 15 were found in significantly more cases in patients with psoriatic arthritis compare to patients with psoriasis - in 206 out of 303 patients (68.2%) and in 310 out of 587 patients (52.8%) accordingly (p < 0.05). Coronary heart disease and atherosclerosis coding as I 70 were found in significantly more cases in patients with psoriatic arthritis compare to patients with psoriasis - in 129 out of 303 patients (42.7%) and in 205 out of 587 patients (34.9%) accordingly (p < 0.05). Cerebrovascular accident coding as I 65 - I 66 were found in significantly more cases in patients with psoriatic arthritis compare to patients with psoriasis - in 50 out of 303 patients (16.6%) and in 64 out of 587 patients (10.9%) accordingly. Conclusions. Psoriatic arthritis and cardiovascular comorbidities are common for hospital-treated cohort patients. Patients with severe plaque psoriasis and psoriatic arthritis tend to suffer from cardiovascular disease and arterial hypertension.